The Business Research Company’s report on the Peptide Antibiotics Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the peptide antibiotics industry?
The increase in the prevalence of various infectious diseases is expected to propel the growth of the peptide antibiotics market. Infectious diseases are illnesses caused by harmful micro-organisms such as bacteria, fungi, parasites, and others. The major reasons for the rise in infectious diseases are rapid urbanization, climate change, increasing risk of disease emergence, and others, which have increased the demand for peptide antibiotics. Peptide antibiotics physically rupture the cell membranes and underpin the antibacterial activity. For instance, in May 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in the America region, dengue cases had already surpassed seven million by April 2024, which is much higher than the 4.6 million cases reported in all of 2023. Therefore, the increase in the incidence of infectious is driving the peptide antibiotics market growth.
Access Your Free Sample of the Global Peptide Antibiotics Market Report – Get Insights Now!
Peptide Antibiotics Market Forecast Report 2025 And Demand, 2034 Sample
What is the estimated market size of the peptide antibiotics sector by 2029, based on current forecasts?
The peptide antibiotics market size has grown rapidly in recent years. It will grow from $5.25 billion in 2024 to $5.82 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to discovery and development of peptide antibiotics, increased antibiotic resistance, rise inThe incidence of infectious diseases, advances in peptide synthesis technologies, growth ofThe pharmaceutical industry.
The peptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $8.47 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emphasis on novel antibiotics development, increasing global incidence of antibiotic-resistant infections, expansion of research and development in antimicrobial peptides, regulatory support for new antibiotic approvals. Major trends in the forecast period include exploration of natural sources for antimicrobial peptides, application of peptide antibiotics in animal health, focus on peptide engineering for enhanced efficacy, development of combination peptide antibiotics, integration of ai and machine learning in peptide antibiotic discovery.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Peptide Antibiotics Market Forecast Report 2025 And Demand, 2034 Customise
Who are the top players in the peptide antibiotics market?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG
What are the major trends in the peptide antibiotics market?
The strategic partnership is a key trend gaining popularity in the peptide antibiotics market. Major companies operating in the peptide antibiotics market are entering into partnerships to expand their market and leverage each other’s resources. For instance, in January 2022, Berkeley Lights, a US-based digital cell biology company, partnered with Aanika Biosciences. In this partnership, Aanika will leverage Berkeley Lights’ high-throughput, functional screening service to swiftly find and refine functional antimicrobial peptides (AMPs) capable of eliminating dangerous bacteria, particularly those that cause foodborne disease outbreaks. Furthermore, the Beacon Optofluidic Platform will be used to identify peptides that are harmful to bacteria in order to develop a novel antibacterial tag, which will then be used in their bacterial spore-based barcoding technology to secure the food supply chain. Aanika Biosciences is a US-based biotechnology company.
Which geography holds the highest peptide antibiotics market share?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
Peptide Antibiotics Market Forecast Report 2025 And Demand, 2034
How do different segments contribute to the overall expansion of the peptide antibiotics market?
The peptide antibiotics market covered in this report is segmented –
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Peptide Antibiotics Market Forecast Report 2025 And Demand, 2034
How is the peptide antibiotics market defined, and what are its core characteristics?
Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
